phenylalanylglutamate has been researched along with gw9662 in 1 studies
| Studies (phenylalanylglutamate) | Trials (phenylalanylglutamate) | Recent Studies (post-2010) (phenylalanylglutamate) | Studies (gw9662) | Trials (gw9662) | Recent Studies (post-2010) (gw9662) |
|---|---|---|---|---|---|
| 5 | 0 | 1 | 617 | 0 | 406 |
| Protein | Taxonomy | phenylalanylglutamate (IC50) | gw9662 (IC50) |
|---|---|---|---|
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | 3.3 | |
| Nuclear receptor ROR-gamma | Homo sapiens (human) | 0.086 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, G; Jiang, H; Liu, H; Liu, Z; Luo, X; Shen, X; Ye, F; Zhu, W | 1 |
1 other study(ies) available for phenylalanylglutamate and gw9662
| Article | Year |
|---|---|
Tryptophan-containing dipeptide derivatives as potent PPARgamma antagonists: design, synthesis, biological evaluation, and molecular modeling.
Topics: Computer Simulation; Dipeptides; Drug Design; Models, Chemical; Models, Molecular; Molecular Structure; PPAR gamma; Stereoisomerism; Structure-Activity Relationship; Tryptophan | 2008 |